CJC-1295 / Ipamorelin
A blended reference material containing CJC-1295 (modified GRF 1-29) and Ipamorelin, supplied for in-vitro laboratory research.
- Material
- CJC-1295 / Ipamorelin
- Form
- Lyophilized powder
- Vial quantity
- 10 mg · 1 vial
- Batch number
- LAN-CI-2608-01
- Testing status
- Testing in progress
- Storage
- Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Supplied for laboratory research use only. Not for human or veterinary use.
Current Batch Analysis
Batch: LAN-CI-2608-01
- Identity
- Pending
- Quantity
- Pending
- Purity
- Pending
- Additional testing
- —
- Independent laboratory
- Pending
- Testing date
- —
Analytical testing in progress. Results and the original laboratory report will be published here once received.
Material Overview
CJC-1295 / Ipamorelin is supplied as a blended peptide reference material. CJC-1295 (without DAC) is a modified growth hormone-releasing factor analogue; Ipamorelin is a synthetic pentapeptide studied as a growth hormone secretagogue receptor ligand. Each batch is submitted for independent analytical testing.
Research Context
Both molecules have been studied in the published literature in relation to growth hormone axis signalling in laboratory and animal models. Research findings do not constitute clinical evidence of efficacy in humans.
Storage & Handling
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Molecular Information
- Peptide sequence
- Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Molecular formula
- CJC-1295: C152H252N44O42 · Ipamorelin: C38H49N9O5
- Molecular weight
- CJC-1295: 3367.9 g/mol · Ipamorelin: 711.85 g/mol
- CAS number
- 863288-34-0 (CJC-1295) · 170851-70-4 (Ipamorelin)
- Synonyms
- Modified GRF (1-29); NNC 26-0161
- Research classification
- Peptide blend reference material